Question 1

Does Franklin Templeton own AUTL stock?

Accepted Answer

No. Franklin Templeton exited its AUTL (Autolus Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 10,000 shares worth $41,800.

Question 2

How many shares of AUTL does Franklin Templeton own?

Accepted Answer

None since Q4 2024, when Franklin Templeton exited the position. Its Q3 2024 13F listed 10,000 shares worth $41,800.

Question 3

What is Franklin Templeton's AUTL position worth?

Accepted Answer

Franklin Templeton's AUTL position was worth $41,800 in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is Franklin Templeton buying or selling AUTL?

Accepted Answer

In Q4 2024, Franklin Templeton exited its entire AUTL position.

Question 5

When did Franklin Templeton first buy AUTL?

Accepted Answer

Franklin Templeton first reported AUTL in its Q1 2020 13F and listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$2.21	0
2024-Q3	Unchanged	10,000	0.0%	$41,800	0.0%	$3.63	0